Enovis Operating Margin 2012-2025 | ENOV
Current and historical operating margin for Enovis (ENOV) over the last 10 years. The current operating profit margin for Enovis as of September 30, 2025 is 8.54%.
| Enovis Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $2.23B | $-1.29B | -57.61% |
| 2025-06-30 | $2.19B | $-0.76B | -34.75% |
| 2025-03-31 | $2.15B | $-0.79B | -36.65% |
| 2024-12-31 | $2.11B | $-0.78B | -36.83% |
| 2024-09-30 | $2.00B | $-0.12B | -5.85% |
| 2024-06-30 | $1.91B | $-0.11B | -5.49% |
| 2024-03-31 | $1.82B | $-0.08B | -4.13% |
| 2023-12-31 | $1.71B | $-0.07B | -3.81% |
| 2023-09-30 | $1.66B | $-0.09B | -5.23% |
| 2023-06-30 | $1.63B | $-0.09B | -5.22% |
| 2023-03-31 | $1.59B | $-0.07B | -4.08% |
| 2022-12-31 | $1.56B | $-0.07B | -4.54% |
| 2022-09-30 | $0.99B | $-0.14B | -14.31% |
| 2022-06-30 | $0.96B | $-0.14B | -14.46% |
| 2022-03-31 | $0.92B | $-0.16B | -16.81% |
| 2021-12-31 | $1.43B | $-0.06B | -4.42% |
| 2021-09-30 | $0.47B | $-0.14B | -28.54% |
| 2021-06-30 | $0.92B | $-0.06B | -6.20% |
| 2021-03-31 | $1.18B | $-0.05B | -4.40% |
| 2020-12-31 | $1.12B | $-0.07B | -5.89% |
| 2020-09-30 | $3.13B | $0.20B | 6.26% |
| 2020-06-30 | $3.17B | $0.20B | 6.37% |
| 2020-03-31 | $3.46B | $0.25B | 7.20% |
| 2019-12-31 | $3.33B | $0.20B | 6.13% |
| 2019-09-30 | $2.67B | $0.12B | 4.54% |
| 2019-06-30 | $2.34B | $0.09B | 3.75% |
| 2019-03-31 | $2.00B | $0.09B | 4.56% |
| 2018-12-31 | $2.19B | $0.15B | 6.89% |
| 2018-09-30 | $1.48B | $0.07B | 4.87% |
| 2018-06-30 | $1.80B | $0.11B | 6.23% |
| 2018-03-31 | $2.09B | $0.14B | 6.57% |
| 2017-12-31 | $1.94B | $0.14B | 6.97% |
| 2017-09-30 | $3.01B | $0.26B | 8.70% |
| 2017-06-30 | $2.93B | $0.25B | 8.38% |
| 2017-03-31 | $3.04B | $0.25B | 8.18% |
| 2016-12-31 | $3.19B | $0.24B | 7.44% |
| 2016-09-30 | $3.13B | $0.23B | 7.22% |
| 2016-06-30 | $3.33B | $0.21B | 6.39% |
| 2016-03-31 | $3.40B | $0.24B | 6.97% |
| 2015-12-31 | $3.43B | $0.27B | 7.75% |
| 2015-09-30 | $4.11B | $0.33B | 7.95% |
| 2015-06-30 | $4.31B | $0.40B | 9.29% |
| 2015-03-31 | $4.48B | $0.40B | 8.91% |
| 2014-12-31 | $4.62B | $0.41B | 8.87% |
| 2014-09-30 | $4.59B | $0.42B | 9.22% |
| 2014-06-30 | $4.44B | $0.41B | 9.17% |
| 2014-03-31 | $4.31B | $0.42B | 9.81% |
| 2013-12-31 | $4.21B | $0.41B | 9.67% |
| 2013-09-30 | $4.06B | $0.34B | 8.34% |
| 2013-06-30 | $4.00B | $0.29B | 7.20% |
| 2013-03-31 | $3.97B | $0.24B | 5.94% |
| 2012-12-31 | $3.91B | $0.14B | 3.58% |
| 2012-09-30 | $3.06B | $0.08B | 2.61% |
| 2012-06-30 | $2.28B | $0.03B | 1.45% |
| 2012-03-31 | $1.42B | $-0.01B | -0.70% |
| 2011-12-31 | $0.69B | $0.03B | 3.60% |
| 2011-09-30 | $0.68B | $0.05B | 7.76% |
| 2011-06-30 | $0.65B | $0.06B | 8.84% |
| 2011-03-31 | $0.58B | $0.05B | 7.75% |
| 2010-12-31 | $0.54B | $0.04B | 6.46% |
| 2010-09-30 | $0.51B | $0.03B | 4.94% |
| 2010-06-30 | $0.50B | $0.03B | 5.17% |
| 2010-03-31 | $0.51B | $0.03B | 5.70% |
| 2009-12-31 | $0.53B | $0.04B | 7.62% |
| 2009-09-30 | $0.55B | $0.05B | 9.58% |
| 2009-06-30 | $0.58B | $0.06B | 11.09% |
| 2009-03-31 | $0.61B | $0.02B | 2.46% |
| 2008-12-31 | $0.60B | $0.02B | 2.98% |
| 2008-09-30 | $0.59B | $0.05B | 7.98% |
| 2008-06-30 | $0.56B | $0.07B | 12.66% |
| 2008-03-31 | $0.52B | $0.12B | 23.75% |
| 2007-12-31 | $0.51B | $0.12B | 24.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.245B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |